ChitogenX Inc. (CSE:CHGX)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Jun 10, 2025, 9:04 AM EST
ChitogenX Balance Sheet
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 |
Cash & Equivalents | 0.05 | 0.04 | 0.11 | 0.31 | 2.38 | 0.3 |
Cash & Short-Term Investments | 0.05 | 0.04 | 0.11 | 0.31 | 2.38 | 0.3 |
Cash Growth | -56.76% | -67.59% | -65.50% | -86.84% | 687.75% | -42.37% |
Other Receivables | 0 | 0.09 | 0.17 | 0.29 | 0.2 | 0.38 |
Receivables | 0 | 0.09 | 0.17 | 0.29 | 0.2 | 0.38 |
Prepaid Expenses | 0.06 | 0.11 | 0.12 | 0.12 | 0.26 | 0.06 |
Total Current Assets | 0.11 | 0.23 | 0.4 | 0.72 | 2.84 | 0.74 |
Property, Plant & Equipment | 0.03 | 0.03 | 0.04 | 0.07 | 0.07 | 0.15 |
Other Intangible Assets | 0.24 | 0.27 | 0.3 | 0.33 | 0.36 | 0.4 |
Total Assets | 0.39 | 0.53 | 0.74 | 1.12 | 3.28 | 1.29 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 |
Accounts Payable | 2.62 | 2.19 | 1.48 | 0.47 | 0.24 | 1 |
Accrued Expenses | 0.89 | 0.48 | 0.64 | 0.32 | 0.22 | 0.08 |
Short-Term Debt | 0.51 | 0.18 | 1.23 | 0.93 | - | 0.6 |
Current Portion of Long-Term Debt | 3.61 | 0.42 | 2.72 | - | 1.85 | - |
Current Portion of Leases | - | - | - | - | - | 0.02 |
Current Unearned Revenue | - | - | - | 0.01 | - | - |
Other Current Liabilities | - | - | 1.15 | 0.14 | - | - |
Total Current Liabilities | 7.63 | 3.27 | 7.22 | 1.87 | 2.31 | 1.69 |
Long-Term Debt | 0.12 | 3.28 | 2.36 | 4.78 | 2.77 | 1.97 |
Long-Term Leases | - | - | - | - | - | 0.02 |
Other Long-Term Liabilities | - | 0.16 | 1 | 1.58 | - | - |
Total Liabilities | 7.75 | 6.71 | 10.58 | 8.23 | 5.08 | 3.69 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 |
Common Stock | 14.2 | 14.2 | 10.36 | 7.89 | 7.71 | 5.42 |
Additional Paid-In Capital | 4.54 | 4.01 | 2.55 | 2.1 | 1.61 | 0.96 |
Retained Earnings | -27.81 | -26.71 | -25.16 | -18.93 | -13.66 | -9.89 |
Comprehensive Income & Other | 1.71 | 2.33 | 2.41 | 1.83 | 2.55 | 1.12 |
Shareholders' Equity | -7.36 | -6.18 | -9.84 | -7.1 | -1.8 | -2.4 |
Total Liabilities & Equity | 0.39 | 0.53 | 0.74 | 1.12 | 3.28 | 1.29 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 |
Total Debt | 4.23 | 3.88 | 6.31 | 5.71 | 4.62 | 2.61 |
Net Cash (Debt) | -4.19 | -3.84 | -6.21 | -5.4 | -2.24 | -2.31 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.05 | -0.05 | -0.13 | -0.15 | -0.08 | -0.09 |
Filing Date Shares Outstanding | 83.13 | 83.13 | 51.04 | 34.96 | 34.91 | 24.75 |
Total Common Shares Outstanding | 83.13 | 83.13 | 51.04 | 34.96 | 34.57 | 24.75 |
Working Capital | -7.52 | -3.04 | -6.83 | -1.15 | 0.53 | -0.95 |
Book Value Per Share | -0.09 | -0.07 | -0.19 | -0.20 | -0.05 | -0.10 |
Tangible Book Value | -7.61 | -6.45 | -10.14 | -7.44 | -2.17 | -2.8 |
Tangible Book Value Per Share | -0.09 | -0.08 | -0.20 | -0.21 | -0.06 | -0.11 |
Machinery | - | 0.27 | 0.27 | 0.27 | 0.24 | 0.24 |